guanfacine
These highlights do not include all the information needed to use GUANFACINE EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for GUANFACINE EXTENDED-RELEAS E TABLETS . GUANFACINE extended-release tablets, for oral use Initial U.S. Approval: 1986
3a171942-37af-430d-8b9d-bb678ca2be4b
HUMAN PRESCRIPTION DRUG LABEL
Jan 31, 2020
Actavis Pharma, Inc.
DUNS: 119723554
Products 4
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
guanfacine
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (11)
guanfacine
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (11)
guanfacine
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (11)
guanfacine
Product Details
FDA regulatory identification and product classification information